In an interview with CNBC-TV18, AN Singh, CMD of Celestial Biolabs said that the company is in process of obtaining raw materials and once the drugs are introduced in the market a 20 percent gain in profitability is expected in last quarter of this fiscal.
first published: Jan 14, 2016 04:40 pm
A collection of the most-viewed Moneycontrol videos.
Live: Nifty reclaims 25,300, registers over 1% gain this week | Closing Bell
Live: Will Nifty bulls aim to break 25,250 after strong TCS Q2? | Opening Bell
TCS Q2 Earnings Live: Margin, Revenue Beat Street Estimates
Live: Nifty reclaims 25,100 ahead of TCS Q2 results; pharma, metals shine | Closing Bell
